Medicare Materials

Your Results

• Big Pharma’s Lies on Drug Prices Debunked

  April 26, 2022: Last week, the Alliance joined the bipartisan patient coalition Patients for Affordable Drugs Now (P4ADN) as it implemented Debunking Big Pharma Week. Throughout the week, P4ADNow highlighted five of Big Pharma’s biggest lies to Read More >

• Arizona Alliance Testifies at Sen. Kelly Hearing on Lowering Prescription Drug Prices

  April 18, 2022: Arizona Senator Mark Kelly chaired a U.S. Senate Special Committee on Aging hearing in Phoenix on Tuesday entitled, “No Time to Wait: Proposals to Lower Prescription Drug Costs.” Arizona experts, advocates, and patients impact Read More >

• Medicare Limits Coverage of Aduhelm to Patients in Clinical Trials

  April 11, 2022: Citing data showing the new Alzheimer’s drug Aduhelm has serious safety risks and may not help patients, Medicare officials decided Thursday to limit coverage of the drug to patients in clinical trials. The decision is extremely Read More >

• Kaiser Health News: Insulin Copay Cap Passes House Hurdle, But Senate Looks for a Broader Bill

  April 06, 2022: Sen. Susan Collins (R-ME) talks to reporters as she heads to the U.S. Capitol on Feb. 7, 2022, in Washington. (CHIP SOMODEVILLA / GETTY IMAGES) The chances of passing election-year legislation to help people afford insulin — Read More >

• Alliance Praises House Passage of Legislation to Reduce the Price of Insulin

  April 04, 2022: The United States House of Representatives passed the Affordable Insulin Now Act, H.R. 6833, by a vote of 232-193 on March 31, capping the cost of insulin at $35 per month for all Medicare beneficiaries and many other Americans of Read More >

• Retirees Praise Legislation to Reduce the Price of Insulin

  March 31, 2022: Statement by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding House passage of H.R. 6833, the "Affordable Insulin Now Act.” “Seniors are applauding the House of Representatives for passing Read More >

• Kaiser Health News: Pharma Cash to Congress

  March 31, 2022: Every year, pharmaceutical companies contribute millions of dollars to U.S. senators and representatives as part of a multipronged effort to influence health care lawmaking and spending priorities. Use this tool to explore the siz Read More >

• Democrats Eye Plans to Substantially Drop the Price of Insulin

  March 28, 2022: Senate Democrats are proposing legislation to cap insulin prices at $35 a month, after previous attempts to reduce drug prices stalled in Congress. The cap would likely be combined with a bipartisan bill targeting pharmacy middlem Read More >

• Senior GOP Sen. Grassley Tells Democrats to Pass Drug Price Legislation Now

  March 21, 2022: Sen. Chuck Grassley (R-Iowa) acknowledged during a Senate Finance Committee hearing Wednesday that it would be difficult to pass legislation lowering drug prices if his own party regains control of Congress following the 2022 midt Read More >

• Generic Drug Manufacturer Announces Plans for Low-Cost Insulin

  March 14, 2022: Uninsured and underinsured Americans often pay the highest out-of-pocket costs for their medicine, forcing many to choose between purchasing the medicine they need and covering essential living expenses. However, the country’s f Read More >